Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) CEO Dagi Shahar Ben-Noon Acquires 18,181 Shares of Company Stock

Inspira Technologies OXY B.H.N. Ltd (NASDAQ:QTEX) CEO Dagi Ben-Noon purchased 18,181 shares of the business’s stock in a transaction on Friday, October 9th. The shares were acquired at an average price of $1.67 per share, for a total transaction of $30,362.27. Following the completion of the acquisition, the chief executive officer directly owned 3,664,314 shares in the company, valued at approximately $6,119,404.38. This represents a 0.50% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Dagi Shahar Ben-Noon also recently made the following trade(s):

• On Monday, September 28th, Dagi Ben-Noon acquired 168,894 shares of Inspira Technologies OXY B.H.N. stock. The shares were bought at an average cost of $0.71 per share, with a total value of $119,914.74.

Inspira Technologies OXY B.H.N. Trading Up 10.7%

NASDAQ:QTEX opened at $1.87 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.00 and a quick ratio of 1.62. Inspira Technologies OXY B.H.N. Ltd has a twelve month low of $0.28 and a twelve month high of $3.85. The company has a fifty day moving average of $0.96.

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) last issued its earnings results on Thursday, September 24th. The company reported ($0.07) earnings per share (EPS) for the quarter. The company had revenue of $0.78 million for the quarter.

Inspira Technologies OXY B.H.N. declared that its Board of Directors has authorized a stock repurchase plan on Monday, June 22nd that authorizes the company to buy back 2,000,000,000,000 outstanding shares. This buyback authorization authorizes the company to purchase up to 5.6% of its shares through open market purchases. Stock buyback plans are often a sign that the company’s board believes its stock is undervalued.

Wall Street Analyst Weigh In

QTEX has been the subject of a number of research analyst reports. Weiss Ratings raised Inspira Technologies OXY B.H.N. from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, September 25th. Wall Street Zen cut Inspira Technologies OXY B.H.N. from a “hold” rating to a “sell” rating in a research note on Saturday, August 8th. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat, Inspira Technologies OXY B.H.N. presently has a consensus rating of “Sell”.

Inspira Technologies OXY B.H.N. Company Profile

Inspira Technologies OXY B.H.N. Ltd. is a medical technology company focused on developing advanced respiratory-support and blood-monitoring solutions for critical-care settings. The company’s technologies are intended to help address complications associated with respiratory failure and improve the management of patients requiring oxygenation support.

Its product portfolio includes the INSPIRA ART system, an extracorporeal respiratory-support platform designed to provide oxygenation while potentially reducing the need for conventional mechanical ventilation or more complex extracorporeal membrane oxygenation procedures.